ATE5049T1 - Chrom-acetylacetonat als diaetetische ergaenzung und pharmazeutisches mittel. - Google Patents
Chrom-acetylacetonat als diaetetische ergaenzung und pharmazeutisches mittel.Info
- Publication number
- ATE5049T1 ATE5049T1 AT80200219T AT80200219T ATE5049T1 AT E5049 T1 ATE5049 T1 AT E5049T1 AT 80200219 T AT80200219 T AT 80200219T AT 80200219 T AT80200219 T AT 80200219T AT E5049 T1 ATE5049 T1 AT E5049T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical agent
- chromium
- dietary supplement
- chromium acetylacetonate
- iii
- Prior art date
Links
- 239000008177 pharmaceutical agent Substances 0.000 title abstract 2
- XEHUIDSUOAGHBW-UHFFFAOYSA-N chromium;pentane-2,4-dione Chemical compound [Cr].CC(=O)CC(C)=O.CC(=O)CC(C)=O.CC(=O)CC(C)=O XEHUIDSUOAGHBW-UHFFFAOYSA-N 0.000 title 1
- 235000015872 dietary supplement Nutrition 0.000 title 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 229910052804 chromium Inorganic materials 0.000 abstract 1
- 239000011651 chromium Substances 0.000 abstract 1
- BFGKITSFLPAWGI-UHFFFAOYSA-N chromium(3+) Chemical compound [Cr+3] BFGKITSFLPAWGI-UHFFFAOYSA-N 0.000 abstract 1
- -1 chromium(III) compound Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/92—Ketonic chelates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Obesity (AREA)
- Animal Husbandry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Seeds, Soups, And Other Foods (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2138279A | 1979-03-19 | 1979-03-19 | |
| EP80200219A EP0016496B1 (de) | 1979-03-19 | 1980-03-07 | Chrom-Acetylacetonat als diätetische Ergänzung und pharmazeutisches Mittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE5049T1 true ATE5049T1 (de) | 1983-11-15 |
Family
ID=21803870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT80200219T ATE5049T1 (de) | 1979-03-19 | 1980-03-07 | Chrom-acetylacetonat als diaetetische ergaenzung und pharmazeutisches mittel. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4571391A (de) |
| EP (1) | EP0016496B1 (de) |
| JP (1) | JPS565414A (de) |
| AT (1) | ATE5049T1 (de) |
| AU (1) | AU536196B2 (de) |
| CA (1) | CA1154672A (de) |
| DE (1) | DE3065342D1 (de) |
| IE (1) | IE49650B1 (de) |
| NZ (1) | NZ193164A (de) |
| ZA (1) | ZA801555B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6831881A (en) * | 1980-03-31 | 1981-10-08 | Procter & Gamble Company, The | Chromium complexes as dietary supplements and pharmaceutical agents |
| JPS5991861A (ja) * | 1982-11-17 | 1984-05-26 | Bikou:Kk | 栄養補助食品カルシウム粒 |
| DE3334516A1 (de) * | 1983-09-23 | 1985-04-11 | Siemens AG, 1000 Berlin und 8000 München | Koppelfeld mit verbindungswegeumkehr, insbesondere fuer fernsprechvermittlungsanlagen |
| DE3783206T2 (de) * | 1986-10-27 | 1993-05-27 | Abbott Lab | Fluessige naehrwert-tabelle fuer glukose-intoleranz. |
| IL95220A0 (en) * | 1989-07-28 | 1991-06-10 | Thymax Corp | Dithiochrome,an insulinbinding molecule,pharmaceutical compositions containing it and methods for extracting it |
| US5420108A (en) * | 1992-09-14 | 1995-05-30 | Shohet; Isaac H. | Method of controlling diabetes mellitus |
| US5811463A (en) * | 1993-10-06 | 1998-09-22 | University Of British Columbia | Compositions and method for relaxing smooth muscles |
| US5631284A (en) * | 1993-10-06 | 1997-05-20 | University Of British Columbia | Compositions and methods for relaxing smooth muscles |
| US20050214384A1 (en) * | 2002-04-23 | 2005-09-29 | Vijaya Juturu | Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance |
| US7247328B2 (en) * | 2002-05-31 | 2007-07-24 | Zinpro Corporation | Chromium (III) alpha amino acid complexes |
| US20060029642A1 (en) * | 2004-08-03 | 2006-02-09 | Dusan Miljkovic | Methods and compositions for improved chromium complexes |
| US20060083824A1 (en) * | 2004-10-20 | 2006-04-20 | Pbm Products Llc | Nutritional supplements for glucose intolerant individuals |
| CA2931881C (en) * | 2007-01-31 | 2018-12-11 | Nutrition 21, Inc. | Use of chromium histidinate for treatment of cardiometabolic disorders |
| CA2681158C (en) | 2007-03-13 | 2018-09-18 | Nutrition 21, Inc. | Methods and compositions for the sustained release of chromium |
| WO2009002867A2 (en) | 2007-06-26 | 2008-12-31 | Nutrition 21, Inc. | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement |
| US9585898B2 (en) | 2008-02-11 | 2017-03-07 | Kenneth O. Russell | Method for the reduction of dangerous blood sugar levels |
| US8932372B2 (en) | 2010-02-02 | 2015-01-13 | Celanese International Corporation | Integrated process for producing alcohols from a mixed acid feed |
| MX344925B (es) | 2011-03-01 | 2017-01-11 | N21 Acquisition Holding Llc | Composiciones de insulina y cromo para el tratamiento y prevención de diabetes, hipoglucemia y alteraciones relacionadas. |
| US11865121B2 (en) | 2016-02-11 | 2024-01-09 | Nutrition21, LLC | Chromium containing compositions for improving health and fitness |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3134797A (en) * | 1960-06-13 | 1964-05-26 | Diamond Alkali Co | Preparation of chromium complexes of beta-diketones |
| US3914410A (en) * | 1972-06-13 | 1975-10-21 | Bristol Myers Co | Method for preparing sucrose composition containing chromium III salt |
| US3925433A (en) * | 1973-09-10 | 1975-12-09 | Zinpro Corp | 1:1 And 2:1 chromium, alpha amino acid complex salts |
-
1980
- 1980-03-07 DE DE8080200219T patent/DE3065342D1/de not_active Expired
- 1980-03-07 AT AT80200219T patent/ATE5049T1/de not_active IP Right Cessation
- 1980-03-07 EP EP80200219A patent/EP0016496B1/de not_active Expired
- 1980-03-17 AU AU56502/80A patent/AU536196B2/en not_active Ceased
- 1980-03-17 CA CA000347821A patent/CA1154672A/en not_active Expired
- 1980-03-18 NZ NZ193164A patent/NZ193164A/en unknown
- 1980-03-18 ZA ZA00801555A patent/ZA801555B/xx unknown
- 1980-03-18 IE IE547/80A patent/IE49650B1/en unknown
- 1980-03-19 JP JP3569380A patent/JPS565414A/ja active Pending
- 1980-11-07 US US06/205,042 patent/US4571391A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IE800547L (en) | 1980-09-19 |
| IE49650B1 (en) | 1985-11-13 |
| CA1154672A (en) | 1983-10-04 |
| AU5650280A (en) | 1980-09-25 |
| US4571391A (en) | 1986-02-18 |
| EP0016496A1 (de) | 1980-10-01 |
| AU536196B2 (en) | 1984-04-19 |
| EP0016496B1 (de) | 1983-10-19 |
| ZA801555B (en) | 1981-04-29 |
| DE3065342D1 (en) | 1983-11-24 |
| NZ193164A (en) | 1984-12-14 |
| JPS565414A (en) | 1981-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE5049T1 (de) | Chrom-acetylacetonat als diaetetische ergaenzung und pharmazeutisches mittel. | |
| FI875533A0 (fi) | Insulinpreparat foer non-parenteral dosering. | |
| DE59309714D1 (de) | Pharmazeutische und/oder kosmetische Zubereitung | |
| ATE76306T1 (de) | Pharmazeutische loesungen die dimethylsulfoxid enthalten. | |
| ATE94877T1 (de) | Piperazinylderivate von purinen und deren isostere als hypoglykaemische wirkstoffe. | |
| PH31617A (en) | Novel thienylcarboxylates of amino alcohols, theirquaternary products and use of these compounds. | |
| DE3786390D1 (de) | Arylaminopyrimidin-derivate, verfahren zu deren herstellung und diese als wirksamen stoff enthaltende insektizide, akarizide und fungizide. | |
| DE3851473D1 (de) | Haarkosmetisches Präparat. | |
| ATE81505T1 (de) | Azacycloalkanderivate, absorptionspromotoren, die die derivate als effektiven inhaltsstoff enthalten und aeusserlich anzuwendende praeparate, die absorptionspromotoren enthalten. | |
| HU910979D0 (en) | Process for the prodiction of medical preparations with n-neuropeptide-antagonistic effect, containing guanidine derivatives | |
| DE3031710C2 (de) | Salze von (+)-catechin, deren herstellung und verwendung sowie diese salze enthaltende pharmazeutische zubereitungen. | |
| ATE70450T1 (de) | Zusammensetzungen aus vanadium und peroxyd als nachahmungsmittel von insulin. | |
| DK261490D0 (da) | New pharmaceutical compound | |
| FI935728A0 (fi) | Substituerade 4-fenylpyridoner och 4-fenyl-2-alkoxipyridiner | |
| KR890012659A (ko) | 조산아의 뇌실내 출혈방지용 치료제 | |
| DK0453603T3 (da) | Piroxicamholdige farmaceutiske præparater til topisk anvendelse | |
| DE58902582D1 (de) | Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe. | |
| DE68903435D1 (de) | Aminoketale, deren herstellung und deren verwendung als fungizides mittel. | |
| DK0553155T3 (da) | Melatoninderiviat med dermatologisk terapeutisk aktivitet | |
| EP0037144A3 (de) | Chromkomplexe als Diätzulage und pharmazeutische Mittel | |
| DE59009378D1 (de) | Diclofenac-Natrium enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung. | |
| Duhault et al. | The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats | |
| ATE2029T1 (de) | Diagnostisches mittel und dessen verwendung zum nachweis von urobilinogen. | |
| KR910021244A (ko) | 당뇨병성 괴저 치료제 | |
| DK0402208T3 (da) | Sammensætning af vitamin A i fysiologisk dosis og forskellige aktive bestanddele med en terapeutisk aktivitet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |